Skip to content

Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector

Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02199977
Enrollment
444
Registered
2014-07-25
Start date
2014-06-30
Completion date
2015-07-31
Last updated
2015-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever, Malaria

Keywords

Malaria, Antimalarial subsidy, Malaria rapid diagnostic test (RDT), public-private partnership

Brief summary

There are compelling medical and public health reasons to reduce unnecessary consumption of antimalarials and strong evidence to support the use of RDTs in malaria case management. The primary study hypothesis to be tested is that clients who know they will receive a subsidy conditional on a positive test are more likely to opt for testing before deciding which drug to buy. The primary endpoint is whether subjects choose to be tested for malaria with a rapid diagnostic test. The secondary endpoint is whether they purchased an artemisinin combination therapy (ACT) or not. The primary outcome of interest is to compare the proportion of participants who choose to receive a free malaria diagnostic test when they can receive a subsidy for a discounted drug conditional on a positive test (Group A compared to Group B) compared to those without the offer of a conditional subsidy. The investigators will use an experimental design that randomly assigns clients to one of four groups. Field workers will canvas households in the study area looking for individuals who have fever or history of fever or illness in the last 24 hours (current illness) who have not yet taken drugs or sought treatment outside the home. Clients who meet the inclusion criteria and give verbal consent to participate will be randomly assigned to one of the four groups. They will be given the location and contact information for their local community health worker who can provide a malaria rapid diagnostic test if they choose to be tested. They will also complete a survey tool. One week later, the field worker will return to interview the participant and determine whether they were tested, what action they took for their illness, what medicine they purchased and how much they paid. The investigators will summarize clients' choice by the four randomized study groups.

Interventions

OTHERFree Malaria Rapid Diagnostic Test

Malaria RDT is offered free if patients choose to be tested

OTHERConditional ACT voucher

Participants will be eligible to receive a drug subsidy for a set amount (in the form of a voucher) conditional on a positive malaria test. When a conditional subsidy is offered, it is valid for use on a Green Leaf approved malaria drug.

OTHERMalaria Rapid Diagnostic test for a charge

Participants can receive a malaria RDT for a set amount (i.e., not for free).

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Moi University
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Client is older than 1 year * Client has fever or history of fever or feeling unwell with a malaria-like illness within the last 24 hours * Client or their parent/legal guardian consents to participate

Exclusion criteria

* Client has signs of severe disease or other problem requiring immediate referral to a community health worker (CHW) / health facility * Client has already sought treatment, purchased medicine or taken medicine for the current illness. Note: If more than one febrile person who meet the inclusion criteria are found in a single household, all of the individuals will be enrolled in the same group, but only one individual (the first enrolled) will be used for the purposes of the analysis.

Design outcomes

Primary

MeasureTime frameDescription
Effect of conditional drug subsidy on proportion of participants who choose to receive a free malaria diagnostic testWithin two days of group assignmentThe primary outcome of interest is to compare the proportion of participants who choose to receive a free malaria diagnostic test when they can receive a subsidy for a discounted drug conditional on a positive test compared to those without the offer of a conditional subsidy.

Secondary

MeasureTime frame
Effect of malaria RDT subsidy on the uptake of testing (free versus paid RDT)Within 2 days of group assignment
Effect of a conditional ACT subsidy on uptake of testing when the RDT is not free.Within 2 days of group assignment

Other

MeasureTime frame
Percent of clients with a negative test, a positive test or no test who choose to purchase an ACT in all four groups.Within 2 days of test results

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026